Valo Health, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Valo Health, Inc. - overview
Established
2019
Location
Boston, MA, US
Primary Industry
Biotechnology
About
Based in Massachusetts, US, and founded in 2019, Valo Health, LLC operates as a technology company that uses human-centric data and AI to enhance the drug discovery and development process. The company was founded by David Berry. In March 2021, Valo Health, LLC received its latest Series B funding from Koch Disruptive Technologies. Valo Health, LLC is a provider of an integrated drug development platform called Opal Computational Platform, an integrated platform that combines machine learning-driven computational capabilities and patient data to develop therapeutic programs across major disease areas.
Valo Health, LLC plans to use its funding from March 2021 for scaling the Opal Computational Platform, working capital, and other general purposes.
Current Investors
Flagship Pioneering, Public Sector Pension Investment Board, HBM Partners
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Bioinformatics, Pharmaceutical Research & Development, Application Integration Software, Medical Software
Website
www.valohealth.com
Verticals
Artificial Intelligence, HealthTech
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.